Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 111 | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 548.05 USD | +1.44% | +8.77% | +14.33% | +38.57% | 138.91 B USD | ||
| 197 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 834.04 USD | +0.90% | +4.03% | +25.93% | +41.11% | 85.87 B USD | ||
| 263 | ARGX argenx SE - American Depositary Shares | 1039.78 USD | +0.16% | +12.13% | +13.64% | +51.67% | 64.35 B USD | ||
| 288 | MRNA Moderna, Inc. - Common Stock | 145.13 USD | +8.86% | +125.88% | +164.64% | +435.14% | 57.94 B USD | ||
| 352 | RVMD Revolution Medicines, Inc. - Common Stock | 209.46 USD | -1.08% | +2.67% | +10.88% | +278.09% | 44.89 B USD | ||
| 445 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 236.22 USD | +3.02% | +4.63% | -13.94% | -47.90% | 31.61 B USD | ||
| 477 | BNTX BioNTech SE - American Depositary Shares | 116.57 USD | +5.12% | +25.05% | +30.27% | +5.14% | 27.97 B USD | ||
| 484 | INSM Insmed Incorporated - Common Stock | 125.77 USD | +0.55% | +0.85% | +17.51% | -22.39% | 27.47 B USD | ||
| 488 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.31 USD | +1.21% | +5.05% | +4.22% | +64.55% | 27.38 B USD | ||
| 505 | ROIV Roivant Sciences Ltd. - Common Shares | 36.30 USD | -1.47% | +0.22% | +3.21% | +98.25% | 26.22 B USD | ||
| 508 | INCY Incyte Corporation - Common Stock | 127.81 USD | +0.46% | +6.37% | +8.62% | +50.36% | 25.91 B USD | ||
| 575 | UTHR United Therapeutics Corporation - Common Stock | 513.12 USD | -1.51% | +2.22% | -3.13% | +65.14% | 22.01 B USD | ||
| 676 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 254.28 USD | +2.24% | +3.83% | -0.20% | +81.63% | 16.51 B USD | ||
| 687 | BBIO BridgeBio Pharma, Inc. - Common Stock | 81.50 USD | -1.74% | +2.97% | -3.02% | +42.98% | 15.93 B USD | ||
| 696 | ASND Ascendis Pharma A/S - American Depositary Shares | 253.29 USD | -0.60% | +2.80% | -0.89% | +23.51% | 15.70 B USD | ||
| 773 | EXEL Exelixis, Inc. - Common Stock | 54.08 USD | +0.73% | +5.52% | -3.10% | +38.52% | 13.40 B USD | ||
| 779 | CORT Corcept Therapeutics Incorporated - Common Stock | 122.25 USD | +0.99% | +6.30% | +33.46% | +66.62% | 13.22 B USD | ||
| 794 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.70 USD | -1.45% | -0.45% | +11.37% | +13.28% | 12.91 B USD | ||
| 818 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 87.11 USD | -0.41% | +0.78% | +1.30% | +122.79% | 12.30 B USD | ||
| 821 | HALO Halozyme Therapeutics, Inc. - Common Stock | 108.17 USD | +1.93% | +9.42% | +31.26% | +61.93% | 12.28 B USD |
Notícias Biotechnology Stocks
Ações da Capricor disparam após extensão de prazo pela FDA
FDA prorroga revisão do Deramiocel da Capricor para novembro
GRI Bio apresentará dados de estudo fase 2a sobre fibrose pulmonar no congresso ERS
Alnylam apresentará dados clínicos sobre ATTR e hipertensão no ESC 2026
Lexicon recebe US$ 10 milhões da Novo Nordisk por marco em droga para obesidade
FibroBiologics nomeia Leigh Steinberg para seu conselho de administração
FDA confirma reunião sobre cateter Helix da BioCardia
Gainers Biotechnology Stocks
LIMN Liminatus Pharma, Inc. - Class A Common Stock | 5.15 | +4581.82% |
SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 3.22 | +1010.34% |
ELAB PMGC Holdings Inc. - Common Stock | 6.66 | +991.80% |
HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.87 | +102.33% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.55 | +38.39% |
NTRBW Nutriband Inc. - Warrant | 0.5000 | +25.06% |
ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 13.45 | +22.38% |
Losers Biotechnology Stocks
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0010 | -52.38% |
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
XCUR Exicure, Inc. - Common Stock | 1.15 | -11.54% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.39 | -11.36% |
CURX Curanex Pharmaceuticals Inc - Common Stock | 4.71 | -10.63% |
HURA TuHURA Biosciences, Inc. - Common Stock | 2.00 | -9.91% |